CAR Activators

The chemical class of CAR activators encompasses a diverse spectrum of compounds designed to modulate the activity of the constitutive androstane receptor (CAR), a pivotal regulator involved in orchestrating drug metabolism and xenobiotic response pathways within the liver. This class of activators can be broadly classified into two categories: direct and indirect activators, each exerting their influence on CAR activity through distinctive mechanisms. Direct activators, exemplified by compounds like Phenobarbital, Rifampicin, CITCO, and TCPOBOP, engage with CAR by directly interacting with its ligand-binding domain. This interaction induces conformational changes within CAR, ultimately enhancing its transactivation capacity. The consequence of this direct activation is the upregulation of CAR-dependent genes, thereby influencing the pathways associated with drug metabolism and xenobiotic response. Notably, the well-established CAR activator, Phenobarbital, serves as a paradigmatic example, underscoring the significance of direct interactions in modulating CAR activity and regulating hepatic drug metabolism.On the other hand, indirect activators, represented by PBDE-47, 6-Formylindolo[3,2-b]carbazole, TCC, β-Naphthoflavone, Omeprazole, TCDD, Aroclor 1254, and Ciprofibrate, exert their influence on CAR activity through diverse signaling pathways. These compounds operate by modulating the aryl hydrocarbon receptor (AhR), pregnane X receptor (PXR), or peroxisome proliferator-activated receptor alpha (PPARα) pathways. The activation of these pathways, in turn, leads to the induction of CAR-responsive genes.